Sharq Clinical Trials

Your trusted clinical trials experts in Central Asia

About Us

Sharq Clinical Trials is a young CRO providing clinical trials services based in Uzbekistan with a potential to grow wider to Kazakhstan and other countries of Central Asia. Currently, we are the only CRO conducting clinical trials in Uzbekistan covering the whole process from site feasibility to drug registration.

Who are we?

We are a professional team with over 10 years of global clinical trials experience combined with strong local expertise. Our focus is quality, strict timeliness and compliance with approved budgets.

What are we capable of?

We provide a range of high-quality CRO services for phase II-IV, with therapeutic expertise in oncology, neurology, cardio-vascular and many other indications.

Among our services are consultancy, project management & monitoring, local regulatory support and others.


Regulatory support

Sharq Clinical Trials provides all kinds of regulatory support: consulting, CT submission and approval, ongoing submissions and registration services

Project management and monitoring

Our employees are our greatest value, all Project Managers and CRAs are medical doctors, biologists or pharmacists. We provide flexible monitoring models from full SDV to risk-based approach.

Clinical supply service and logistic

We are constantly working with leading logistics companies in Uzbekistan to provide high quality of clinical supplies services as we understand that this is the key area to deliver clinical trials.

Quality assurance

Sharq Clinical Trials has implemented QA processes to ensure the quality of clinical trials. Our team supports preparation and conduct of audits and inspections, including FDA/EMA.

Drug registration

Our company provides high quality drug registration services with experience of over 10 years on the local market.

Why Uzbekistan?

  • Very competitive budgets costs (in comparison with EU and Russian markets)
  • Very high level of motivation to participate in clinical studies in patients due to unmet treatment needs, and therefore a large pool of "treatment-naïve" patients
  • Huge country population in region of over 30 million people with demographic split of ~ 65% Caucasians and 35% Asians
  • Very few ongoing clinical trials meaning no competition for patients’ population
  • Highly equipped medical institutions with all necessary facilities
  • Initiative steps which have been taken by the Uzbekistan government towards development of the clinical trials in the country